Tom1L-1 inhibitors belong to a class of chemical compounds designed to modulate the activity of the Tom1-like protein 1 (Tom1L-1), a member of the Tom1 family of proteins. These inhibitors are primarily utilized in laboratory research settings to investigate the biological functions and molecular pathways associated with Tom1L-1. Tom1L-1 is a cytoplasmic protein known to play crucial roles in cellular processes, particularly in endosomal trafficking and protein sorting within the cell. It functions as an adapter protein, facilitating interactions between membrane-associated proteins and downstream signaling molecules. By inhibiting Tom1L-1, researchers aim to gain insights into its regulatory functions and the consequences of its perturbation on various cellular processes.
The mechanism of action of Tom1L-1 inhibitors typically involves interfering with the binding or activity of Tom1L-1 within the cell. These inhibitors can function by directly binding to Tom1L-1, thus blocking its interactions with target proteins, or by disrupting the formation of protein complexes involving Tom1L-1. This interference can lead to altered endosomal trafficking patterns, affecting the sorting and trafficking of cargo proteins within the endocytic pathway. By studying the effects of Tom1L-1 inhibition, researchers aim to unravel its role in cellular homeostasis and disease processes. Tom1L-1 inhibitors are valuable tools in deciphering the intricate mechanisms underlying endosomal dynamics, vesicle trafficking, and protein sorting, contributing to our broader understanding of fundamental cellular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aspirin | 50-78-2 | sc-202471 sc-202471A | 5 g 50 g | $20.00 $41.00 | 4 | |
Inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis and inflammation. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Targets tyrosine kinases, especially BCR-ABL, to inhibit cell proliferation in chronic myeloid leukemia (CML). | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $66.00 | 4 | |
Proton pump inhibitor that blocks gastric acid production by inhibiting the H+/K+ ATPase enzyme in parietal cells. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Inhibits multiple kinases, including RAF and VEGFR, to disrupt cancer cell signaling and angiogenesis. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Inhibits dihydrofolate reductase (DHFR), disrupting DNA synthesis and cell division in rapidly dividing cells. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $256.00 | 18 | |
Selective estrogen receptor modulator (SERM) used in breast cancer therapy by blocking estrogen receptor signaling. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $77.00 | 2 | |
Activates AMP-activated protein kinase (AMPK) to lower blood glucose levels and improve insulin sensitivity. | ||||||
Ritonavir | 155213-67-5 | sc-208310 | 10 mg | $122.00 | 7 | |
Protease inhibitor used for HIV/AIDS by inhibiting the HIV-1 protease enzyme, blocking viral replication. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $128.00 | ||
Inhibits xanthine oxidase, reducing uric acid production and used for gout and hyperuricemia. | ||||||
Ciprofloxacin | 85721-33-1 | sc-217900 | 1 g | $42.00 | 8 | |
Inhibits bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication and transcription in bacteria. | ||||||